The National Cancer Institute’s Co-Clinical Quantitative Imaging Research Resources for Precision Medicine in Preclinical and Clinical Settings
Genetically engineered mouse models (GEMMs) and patient-derived xenograft mouse models (PDXs) can recapitulate important biological features of cancer. They are often part of precision medicine studies in a co-clinical setting, in which therapeutic investigations are conducted in patients and in par...
Main Author: | Huiming Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Tomography |
Subjects: | |
Online Access: | https://www.mdpi.com/2379-139X/9/3/76 |
Similar Items
-
Advances in optical imaging for clinical medicine /
by: Iftimia, Nicusor, et al.
Published: (c201) -
Co-Clinical Trials: An Innovative Drug Development Platform for Cholangiocarcinoma
by: Brinda Balasubramanian, et al.
Published: (2021-01-01) -
Co-Clinical Imaging Metadata Information (CIMI) for Cancer Research to Promote Open Science, Standardization, and Reproducibility in Preclinical Imaging
by: Stephen M. Moore, et al.
Published: (2023-05-01) -
Animal Models and Their Role in Imaging-Assisted Co-Clinical Trials
by: Donna M. Peehl, et al.
Published: (2023-03-01) -
Medical imaging in clinical trials /
by: Miller, Colin G., 1960-, editor, et al.
Published: (2014)